FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178721713> ?p ?o ?g. }

• W3178721713 endingPage "2398" @default.
• W3178721713 startingPage "2387" @default.
• W3178721713 abstract "Summary Relapse of acute leukemia is a frequent complication with uncertain outcome and poorly defined risk factors. From 1621 patients entered into two prospective clinical trials (AML02; n = 740 and AML04; n = 881), 74.2% reached complete remission (CR) 1 after induction(s) and 59 patients after additional induction ± hematopoietic cell transplantation (HCT). Of the non-refractory patients, 48.4% with a median age of 63 (range 17–85) years relapsed. Relapses occurred within 6 months after CR in 46.5%, between 7 and 18 months in 38.7%, and after 18 months in 14.8% of patients. Relapse treatment resulted in CR2 in 39% of patients depending upon age (54.5% of ≤ 60 and 28.6% of > 60 years), duration of CR1, and treatment of relapse. Overall survival (OS) was 10.9 (7.4–16.2) %, but OS after HCT ± intensive chemotherapy (ICT) was 39.3% (31.8–48.6) at 5 years and not different in younger and older patients. Donor lymphocyte infusion ± chemotherapy and ICT alone resulted only in OS of 15.4% and of 5%, respectively. Independent favorable factors for OS were long CR1 duration, and HCT, while non-monosomal disease was beneficial for OS in elderly patients. Leukemia-free survival [LFS; 24.9 (19.5–31.7) % at 10 years] was affected by similar risk factors. In a competing risk model, the relapse incidence at 5 years was 53.5 ± 3.5% and the non-relapse mortality rate 21.7 ± 2.9%. Lower relapse incidence was observed in patents with HCT, long CR1 duration, and female gender. Risk factors for non-relapse mortality were HCT in younger and type of AML in elderly patients. In conclusion, allogeneic HCT ± IC improved the results in relapsed AML in younger and elderly patients. Increasing CR2 rates and HCT frequency will be the challenge for the next years. Relapse of the disease remains the major problem." @default.
• W3178721713 created "2021-07-19" @default.
• W3178721713 creator A5011756722 @default.
• W3178721713 creator A5016461300 @default.
• W3178721713 creator A5018364683 @default.
• W3178721713 creator A5022644839 @default.
• W3178721713 creator A5023706722 @default.
• W3178721713 creator A5024649910 @default.
• W3178721713 creator A5024967236 @default.
• W3178721713 creator A5035964802 @default.
• W3178721713 creator A5038260375 @default.
• W3178721713 creator A5042734609 @default.
• W3178721713 creator A5054896832 @default.
• W3178721713 creator A5056804809 @default.
• W3178721713 creator A5057074442 @default.
• W3178721713 creator A5058914292 @default.
• W3178721713 creator A5060270110 @default.
• W3178721713 creator A5069042392 @default.
• W3178721713 creator A5070230907 @default.
• W3178721713 creator A5077620734 @default.
• W3178721713 creator A5078376583 @default.
• W3178721713 creator A5087227508 @default.
• W3178721713 creator A5087351196 @default.
• W3178721713 creator A5090119518 @default.
• W3178721713 date "2021-07-07" @default.
• W3178721713 modified "2023-10-09" @default.
• W3178721713 title "Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials" @default.
• W3178721713 cites W1534965621 @default.
• W3178721713 cites W1568498224 @default.
• W3178721713 cites W1709114039 @default.
• W3178721713 cites W1773696486 @default.
• W3178721713 cites W1973392550 @default.
• W3178721713 cites W1986979976 @default.
• W3178721713 cites W2017196865 @default.
• W3178721713 cites W2038981426 @default.
• W3178721713 cites W2065559112 @default.
• W3178721713 cites W2065738117 @default.
• W3178721713 cites W2066886754 @default.
• W3178721713 cites W2066915026 @default.
• W3178721713 cites W2073140442 @default.
• W3178721713 cites W2090352304 @default.
• W3178721713 cites W2097192169 @default.
• W3178721713 cites W2110893339 @default.
• W3178721713 cites W2116858301 @default.
• W3178721713 cites W2131747601 @default.
• W3178721713 cites W2141773875 @default.
• W3178721713 cites W2148047805 @default.
• W3178721713 cites W2158682205 @default.
• W3178721713 cites W2162700652 @default.
• W3178721713 cites W2167584739 @default.
• W3178721713 cites W2318674152 @default.
• W3178721713 cites W2324265531 @default.
• W3178721713 cites W2345078020 @default.
• W3178721713 cites W2406961927 @default.
• W3178721713 cites W2537595153 @default.
• W3178721713 cites W2559537906 @default.
• W3178721713 cites W2574204554 @default.
• W3178721713 cites W2751836190 @default.
• W3178721713 cites W2783500974 @default.
• W3178721713 cites W2802234295 @default.
• W3178721713 cites W2808694334 @default.
• W3178721713 cites W2902301444 @default.
• W3178721713 cites W2948900598 @default.
• W3178721713 cites W2982353618 @default.
• W3178721713 cites W3035592857 @default.
• W3178721713 cites W3038313191 @default.
• W3178721713 cites W3042846071 @default.
• W3178721713 cites W3083045366 @default.
• W3178721713 doi "https://doi.org/10.1007/s00277-021-04565-1" @default.
• W3178721713 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8357692" @default.
• W3178721713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34529106" @default.
• W3178721713 hasPublicationYear "2021" @default.
• W3178721713 type Work @default.
• W3178721713 sameAs 3178721713 @default.
• W3178721713 citedByCount "9" @default.
• W3178721713 countsByYear W31787217132022 @default.
• W3178721713 countsByYear W31787217132023 @default.
• W3178721713 crossrefType "journal-article" @default.
• W3178721713 hasAuthorship W3178721713A5011756722 @default.
• W3178721713 hasAuthorship W3178721713A5016461300 @default.
• W3178721713 hasAuthorship W3178721713A5018364683 @default.
• W3178721713 hasAuthorship W3178721713A5022644839 @default.
• W3178721713 hasAuthorship W3178721713A5023706722 @default.
• W3178721713 hasAuthorship W3178721713A5024649910 @default.
• W3178721713 hasAuthorship W3178721713A5024967236 @default.
• W3178721713 hasAuthorship W3178721713A5035964802 @default.
• W3178721713 hasAuthorship W3178721713A5038260375 @default.
• W3178721713 hasAuthorship W3178721713A5042734609 @default.
• W3178721713 hasAuthorship W3178721713A5054896832 @default.
• W3178721713 hasAuthorship W3178721713A5056804809 @default.
• W3178721713 hasAuthorship W3178721713A5057074442 @default.
• W3178721713 hasAuthorship W3178721713A5058914292 @default.
• W3178721713 hasAuthorship W3178721713A5060270110 @default.
• W3178721713 hasAuthorship W3178721713A5069042392 @default.
• W3178721713 hasAuthorship W3178721713A5070230907 @default.
• W3178721713 hasAuthorship W3178721713A5077620734 @default.
• W3178721713 hasAuthorship W3178721713A5078376583 @default.
• W3178721713 hasAuthorship W3178721713A5087227508 @default.

• next